|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.74 EUR | -2.07% |
|
-3.17% | +42.71% |
| Capitalization | 36.53B 42.49B 34.22B 31.89B 58.91B 3,824B 64.08B 400B 155B 1,806B 159B 156B 6,604B | P/E ratio 2025 * |
23.9x | P/E ratio 2026 * | 11.5x |
|---|---|---|---|---|---|
| Enterprise value | 65.84B 76.6B 61.68B 57.49B 106B 6,894B 116B 721B 279B 3,256B 287B 281B 11,904B | EV / Sales 2025 * |
1.63x | EV / Sales 2026 * | 1.65x |
| Free-Float |
78.6% | Yield 2025 * |
5.58% | Yield 2026 * | 5.71% |
Last Transcript: Orange
| 1 day | -2.07% | ||
| 1 week | -3.17% | ||
| Current month | -3.17% | ||
| 1 month | -3.00% | ||
| 3 months | +0.84% | ||
| 6 months | +8.40% | ||
| Current year | +42.71% |
| 1 week | 13.72 |  | 14.12 |
| 1 month | 13.61 | | 14.38 |
| Current year | 9.44 | | 14.56 |
| 1 year | 9.37 | | 14.56 |
| 3 years | 9.1 | | 14.56 |
| 5 years | 8.93 | | 14.56 |
| 10 years | 8.63 | | 16.67 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 2022-04-03 | |
| Director of Finance/CFO | 57 | 2023-08-31 | |
Bruno Zerbib
CTO | Chief Tech/Sci/R&D Officer | - | 2023-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Anne Lange
BRD | Director/Board Member | 57 | 2015-05-26 |
| Director/Board Member | 53 | 2016-12-07 | |
| Director/Board Member | 51 | 2017-07-25 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.07% | -3.17% | +41.24% | +47.20% | 42.49B | |
| -0.75% | -1.42% | +16.89% | +68.29% | 246B | |
| +1.04% | +1.41% | -1.60% | +12.16% | 176B | |
| +0.51% | -0.76% | -9.97% | +42.24% | 153B | |
| -1.35% | -2.34% | +25.05% | +84.23% | 86.01B | |
| +0.06% | -1.09% | -0.84% | +4.21% | 81.39B | |
| -1.36% | -6.71% | +29.97% | +7.05% | 64.96B | |
| +0.88% | -2.34% | +49.51% | +73.21% | 58.25B | |
| -0.52% | -0.94% | +5.51% | +16.94% | 56.26B | |
| 0.00% | +0.11% | +11.37% | -22.61% | 43.61B | |
| Average | -0.37% | -1.00% | +16.71% | +33.29% | 100.7B | |
| Weighted average by Cap. | -0.20% | -0.55% | +11.74% | +39.36% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 40.36B 46.95B 37.81B 35.24B 65.09B 4,225B 70.79B 442B 171B 1,996B 176B 172B 7,297B | 40.72B 47.37B 38.14B 35.55B 65.67B 4,263B 71.43B 446B 172B 2,013B 178B 174B 7,362B |
| Net income | 1.52B 1.77B 1.43B 1.33B 2.46B 159B 2.67B 16.68B 6.44B 75.28B 6.65B 6.51B 275B | 3.14B 3.65B 2.94B 2.74B 5.07B 329B 5.51B 34.42B 13.29B 155B 13.72B 13.42B 568B |
| Net Debt | 29.31B 34.1B 27.46B 25.6B 47.28B 3,069B 51.42B 321B 124B 1,450B 128B 125B 5,300B | 30.58B 35.58B 28.65B 26.7B 49.32B 3,202B 53.65B 335B 129B 1,512B 134B 131B 5,529B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-05 | 13.74 € | -2.07% | 3,626,633 |
| 25-12-04 | 14.03 € | -0.39% | 3,635,732 |
| 25-12-03 | 14.08 € | +0.11% | 4,254,491 |
| 25-12-02 | 14.07 € | -0.53% | 3,830,400 |
| 25-12-01 | 14.14 € | -0.32% | 2,912,499 |
Real-time Euronext Paris, December 05, 2025 at 11:55 am EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ORA Stock
Select your edition
All financial news and data tailored to specific country editions
